IL131864A0 - Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist - Google Patents
Pharmaceutical compositions comprising an adenosine receptor agonist or antagonistInfo
- Publication number
- IL131864A0 IL131864A0 IL13186499A IL13186499A IL131864A0 IL 131864 A0 IL131864 A0 IL 131864A0 IL 13186499 A IL13186499 A IL 13186499A IL 13186499 A IL13186499 A IL 13186499A IL 131864 A0 IL131864 A0 IL 131864A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonist
- pharmaceutical compositions
- receptor agonist
- adenosine receptor
- adenosine
- Prior art date
Links
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13186499A IL131864A0 (en) | 1999-09-10 | 1999-09-10 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
IL13368099A IL133680A0 (en) | 1999-09-10 | 1999-12-23 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
DE60037277T DE60037277T2 (en) | 1999-09-10 | 2000-09-08 | ADENOSINE RECEPTOR AGONIST OR ANTAGONIST-CONTAINING PHARMACEUTICAL COMPOSITIONS |
HU0203870A HU226913B1 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
JP2001522994A JP4980530B2 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical composition comprising an adenosine receptor agonist or antagonist |
PT00956773T PT1261322E (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
PCT/IL2000/000550 WO2001019360A2 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
RU2002109228/15A RU2239455C2 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions containing agonist or antagonist of adenosine receptor |
CNB008148007A CN100358512C (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
EP00956773A EP1261322B1 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
CA002384111A CA2384111C (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
ES00956773T ES2296637T3 (en) | 1999-09-10 | 2000-09-08 | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTAGONIST OR AN ADENOSINE RECEIVER AGONIST. |
MXPA02002546A MXPA02002546A (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist. |
KR1020067006473A KR100674529B1 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical Compositions Comprising an Adenosine Receptor Agonist or Antagonist |
PL356469A PL199852B1 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
CNA2007101850427A CN101164548A (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
US09/700,751 US7064112B1 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
AU68634/00A AU782826B2 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
KR1020027003164A KR100584797B1 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical Compositions Comprising an Adenosine Receptor Agonist or Antagonist |
DK00956773T DK1261322T3 (en) | 1999-09-10 | 2000-09-08 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
BR0013905-0A BR0013905A (en) | 1999-09-10 | 2000-09-08 | Use of an active ingredient, pharmaceutical composition, methods for inducing g-csf secretion within an individual's body for therapeutic treatment, for inducing proliferation or differentiation of bone marrow or white blood cells in an individual for prevention or treatment. leukopenia, for the prevention or treatment of toxic side effects of a drug, to inhibit abnormal cell growth, to treat cancer, and to use a3rag |
HK03105018.4A HK1052653B (en) | 1999-09-10 | 2003-07-11 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
US11/286,376 US20060084626A1 (en) | 1999-09-10 | 2005-11-25 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
JP2007128137A JP2007204496A (en) | 1999-09-10 | 2007-05-14 | Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13186499A IL131864A0 (en) | 1999-09-10 | 1999-09-10 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
IL131864A0 true IL131864A0 (en) | 2001-03-19 |
Family
ID=11073243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13186499A IL131864A0 (en) | 1999-09-10 | 1999-09-10 | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101164548A (en) |
IL (1) | IL131864A0 (en) |
-
1999
- 1999-09-10 IL IL13186499A patent/IL131864A0/en unknown
-
2000
- 2000-09-08 CN CNA2007101850427A patent/CN101164548A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101164548A (en) | 2008-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1052653A1 (en) | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist | |
HUP0203638A3 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use | |
HUP0201545A2 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them | |
AU1845402A (en) | Nmda receptor agonist pharmaceutical compositions | |
HUP0401437A3 (en) | Adenosine a3 receptor agonists | |
PT1192169E (en) | A2A RECEPTOR AGONIST C-PYRAZOLES | |
IS5706A (en) | Adenosine A3 receptor antagonists | |
EP1187614A4 (en) | Substituted piperidines as melanocortin-4 receptor agonists | |
HK1049007B (en) | Adenosine a2a receptor antagonists | |
IL142958A0 (en) | Vitronectin receptor antagonist pharmaceuticals | |
EG24194A (en) | 5ht-a-partial agonist pharmaceutical compositions | |
PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
IL160715A0 (en) | Pharmaceutical compositions containing an a1 adenosine receptor antagonist | |
HUP0201300A3 (en) | Il-8 receptor antagonist imidazoidinylidene-2-imino derivatives and pharmaceutical compositions containing them | |
EG24025A (en) | Vitronectin receptor antagonist | |
HUP0203603A3 (en) | Novel il-8 receptor antagonist indole derivatives and pharmaceutical compositions containing them | |
AU4980999A (en) | A3 adenosine receptor antagonists | |
AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
HUP0200057A2 (en) | Dopamine d1 receptor agonist compounds, pharmaceutical compositions containing them and their use | |
IL131864A0 (en) | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist | |
AU2002302774A1 (en) | Macrophage receptor agonist or antagonist | |
SI1347760T1 (en) | Nmda receptor agonist pharmaceutical compositions | |
IL165716A0 (en) | Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists | |
HU0800727D0 (en) | Pharmaceutical composition containing opioid agonistand antagonist combination | |
GB0015901D0 (en) | Compositions containing 5ht receptor agonists |